In this study we show that Deuterium Magnetic Resonance Spectroscopy (DMRS) of the mouse brain after a bolus application of [6,6’-2H2]glucose is feasible at a high SNR and time resolution. We demonstrate that this can be applied to a transgenic mouse model of Alzheimer disease showing clear differences in the glucose uptake and metabolism with a WT mouse. In Deuterium Metabolic Imaging (DMI) mode this could be an alternative approach for FDG PET in Alzheimer disease.
This abstract and the presentation materials are available to members only; a login is required.